Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Exploring MFN Policy Effectiveness in Drug Pric...
By
João L. Carapinha
February 19, 2026
MFN Policy Effectiveness in Countering Freeloading Claims The MFN policy effectiveness is evident in the coalition letter dated February 12, 2026, which opposes codifying Mos...
Strategic Vision and Infarmed 2026 Priorities for Regulatory Reform
South Africa Health Reform: Navigating Innovations and Challenges for 2026
Launch of TrumpRx Drug Pricing: Savings on Essential Medications
Healthcare Innovation Trends Shaping the Future: Insights from the J.P. Morga...
Navigating Economic Resilience Through Life Sciences Investment
Guiding Principles for Ethical AI Integration in Drug Development
Empowering Leaders at the Global Pharma Executive Course: Navigating Industry...
Driving Economic Transformation through Brain Health Investment in Africa
Novartis Drug Pricing Agreement
INFARMED Leadership Appointments: A New Era in Health Regulation and Expertise
Preparing for the EU Health Technology Assessment: Key Insights from the Upco...
Transforming EU Pharmaceutical Legislation: EMA’s Strategic Priorities ...
1
2
3
…
13
Next »